Exenatide significantly improved 24-hour average glucose compared to sitagliptin in patients with type 2 diabetes

被引：0
|
作者：
Shenouda, S. K. [1 ]
Holcombe, J. H. [2 ]
Heilmann, C. R.
机构：
[1] Eli Lilly & Co, Global Med Commun, Indianapolis, IN 46285 USA
[2] Lilly USA LLC, Indianapolis, IN USA
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
831
引用
收藏
页数：1
相关论文
共 50 条
  • [31] First ever 24-hour central blood pressure in patients with type 1 diabetes
    Theilade, S.
    Lajer, M.
    Joergensen, C.
    Persson, F.
    Andresdottir, G.
    Reinhard, H.
    Nielsen, S. E.
    Lacy, P.
    Williams, B.
    Rossing, P.
    DIABETOLOGIA, 2012, 55 : S504 - S504
  • [32] A COMPARISON OF COSTS AMONG PATIENTS WITH TYPE 2 DIABETES WHO INITIATED THERAPY WITH EXENATIDE OR SITAGLIPTIN
    Lage, M. J.
    Misurski, D. A.
    Fabunmi, R.
    Boye, K. S.
    VALUE IN HEALTH, 2008, 11 (06) : A501 - A501
  • [33] Whole 24-hour continuous glucose monitoring profiles with insulin glargine or oral antidiabetic drug therapy in patients with type 2 diabetes mellitus
    Yale, J. -F.
    Harris, S.
    Stewart, J. A.
    Gerstein, H. C.
    DIABETOLOGIA, 2008, 51 : S431 - S431
  • [34] Effects of Dapagliflozin (DAPA), a Sodium Glucose Cotransporter 2 Inhibitor, on 24-Hour Glycemic Control in Patients with Type 2 Diabetes (T2D)
    Henry, Robert R.
    Strange, Poul
    Zhou, Rong
    Zhuplatov, Sergey B.
    Mansfield, Traci
    Klein, David
    Katz, Arie
    DIABETES, 2016, 65 : A311 - A311
  • [35] Sitagliptin Monotherapy improved glycaemic control in patients with type 2 diabetes
    Aschner, P.
    Kipnes, M.
    Lunceford, J.
    Sanchez, M.
    Mickel, C.
    Davies, M. J.
    Williams-Herman, D.
    DIABETOLOGIA, 2006, 49 : 5 - 5
  • [36] RELATIONSHIP BETWEEN 24-HOUR BLOOD PRESSURE VARIABILITY AND TARGET ORGAN DAMAGE IN PATIENTS WITH TYPE 2 DIABETES
    Uzu, T.
    Izumiya, T.
    Nakao, K.
    Kume, S.
    Araki, H.
    Araki, S.
    Maegawa, H.
    JOURNAL OF HYPERTENSION, 2015, 33 : E159 - E159
  • [37] 24-HOUR SYSTOLIC BLOOD PRESSURE IS INDEPENDENTLY ASSOCIATED WITH DIABETIC RETINOPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Turan, Y.
    Turan, E.
    JOURNAL OF HYPERTENSION, 2017, 35 : E48 - E48
  • [38] Sitagliptin or exenatide once weekly for type 2 diabetes: comparison of the clinical trials
    Doggrell, Sheila A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (13) : 2055 - 2067
  • [39] Sitagliptin, a DPP-4 inhibitor, administered once- or twice-daily, provides substantial improvement in 24-hour glucose control in Japanese patients with type 2 diabetes mellitus (T2DM)
    Nonaka, Kenji
    Tsubouchi, Hiroshi
    Okuyama, Kotoba
    Fukao, Yukako
    Stein, Peter P.
    DIABETES, 2007, 56 : A540 - A540
  • [40] Effect of Moderate-Intensity Exercise Versus Activities of Daily Living on 24-Hour Blood Glucose Homeostasis in Male Patients With Type 2 Diabetes
    van Dijk, Jan-Willem
    Venema, Maarten
    van Mechelen, Willem
    Stehouwer, Coen D. A.
    Hartgens, Fred
    van Loon, Luc J. C.
    DIABETES CARE, 2013, 36 (11) : 3448 - 3453
12345